Literature DB >> 7734974

Concentrations of chemical mediators in nasal secretions after nasal allergen challenges in atopic patients.

D Wang1, P Clement, J Smitz, M P Derde.   

Abstract

By using a microsuction technique, a quantitative determination of chemical mediators in nasal secretions was performed in 18 hay-fever patients and in a control group of 10 healthy volunteers. The authors then compared these quantitative data for mediators with objective nasal findings counting the number of sneezes, passive anterior rhinomanometry (PAR) and nasal inspiratory peak flow. A sampling protocol was designed with a follow-up of 3 days after nasal allergen challenge (NAC) in order to investigate both early and late allergic reactions. Median baseline concentrations of five major mediators were obtained: histamine, 19 ng/g; leukotriene C4 (LTC4), 5.7 ng/g. tryptase, 0; prostaglandin D2 (PGD2), 477 pg/g; eosinophil cationic protein (ECP), 105 ng/g. Significant increases in histamine (214 ng/g), LTC4 (20 ng/g) and tryptase (28 microU/g) were found, but a significant decrease occurred in ECP (47 ng/g) and PGD (226 pg/g) immediately after NAC in the patients studied. Most ECP concentrations (94%) increased slowly 1 h after NAC and reached a significantly higher level 24 h later. In evaluating nasal symptoms, sneezes were present in a high percentage of cases (76%) during the early phase but were uncommon during the late phase (29%). Total nasal obstruction occurred in 94% during the early phase. In contrast, unilateral nasal obstruction presented in 82% during the late phase, whereas total nasal obstruction was present only in 41%. The most common type of late phase nasal obstruction shown by PAR was alternating nasal obstruction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7734974     DOI: 10.1007/bf02484433

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  10 in total

1.  Tryptase in nasal lavage fluid after local allergen challenge. Relationship to histamine levels and TAME-esterase activity.

Authors:  S Juliusson; K Holmberg; C R Baumgarten; M Olsson; I Enander; U Pipkorn
Journal:  Allergy       Date:  1991-08       Impact factor: 13.146

2.  Observations on the pathogenesis of nasal priming.

Authors:  M Wachs; D Proud; L M Lichtenstein; A Kagey-Sobotka; P S Norman; R M Naclerio
Journal:  J Allergy Clin Immunol       Date:  1989-10       Impact factor: 10.793

3.  Inflammatory mediators in nasal secretions during induced rhinitis.

Authors:  R M Naclerio; D Proud; S P Peters; G Silber; A Kagey-Sobotka; N F Adkinson; L M Lichtenstein
Journal:  Clin Allergy       Date:  1986-03

4.  Mediator release after nasal airway challenge with allergen.

Authors:  R M Naclerio; H L Meier; A Kagey-Sobotka; N F Adkinson; D A Meyers; P S Norman; L M Lichtenstein
Journal:  Am Rev Respir Dis       Date:  1983-10

5.  Nasal provocation and passive anterior rhinomanometry (PAR).

Authors:  P A Clement; A van Dishoeck; J van de Wal; P Stoop; T Hoek; R van Strick
Journal:  Clin Allergy       Date:  1981-05

6.  Comparison of nasal responsiveness to histamine, methacholine and phentolamine in allergic rhinitis patients and controls.

Authors:  R Gerth Van Wijk; P H Dieges
Journal:  Clin Allergy       Date:  1987-11

7.  Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: effect of the glucocorticoid budesonide.

Authors:  H Bisgaard; H Grønborg; N Mygind; R Dahl; N Lindqvist; P Venge
Journal:  J Allergy Clin Immunol       Date:  1990-05       Impact factor: 10.793

8.  Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure.

Authors:  C Svensson; M Andersson; C G Persson; P Venge; U Alkner; U Pipkorn
Journal:  J Allergy Clin Immunol       Date:  1990-05       Impact factor: 10.793

9.  Nasal secretions from patients with polyps and healthy individuals, collected with a new aspiration system: evaluation of total protein and immunoglobulin concentrations.

Authors:  J Biewenga; A E Stoop; H E Baker; S J Swart; J J Nauta; G J van Kamp; S van der Baan
Journal:  Ann Clin Biochem       Date:  1991-05       Impact factor: 2.057

10.  Eosinophil cationic protein in the nasal secretions of patients with mite allergic rhinitis.

Authors:  K Nishioka; C Saito; T Nagano; M Okano; Y Masuda; T Kuriyama
Journal:  Laryngoscope       Date:  1993-02       Impact factor: 3.325

  10 in total
  2 in total

1.  Augmentation of allergic inflammation in prostanoid IP receptor deficient mice.

Authors:  Yoshimasa Takahashi; Shota Tokuoka; Taisei Masuda; Yousuke Hirano; Masafumi Nagao; Hiroyuki Tanaka; Naoki Inagaki; Shuh Narumiya; Hiroichi Nagai
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

Review 2.  Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis.

Authors:  M Peters-Golden; M M Gleason; A Togias
Journal:  Clin Exp Allergy       Date:  2006-06       Impact factor: 5.018

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.